Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01656681 · ClinicalTrials.gov registry record · NA
Effect of a Novel Nutraceutical on Weight Loss and Weight Maintenance in Obese Subjects
A NA study of Obesity, sponsored by MetaProteomics.
- Completed
- Registry status
- NA
- Development phase
- 130
- Enrollment target
- 1
- Study location
NCT01656681: Completed NA study of Obesity, sponsored by MetaProteomics.
NCT01656681 is a NA study of Obesity that has completed, run by MetaProteomics. The registered enrollment target is 130 participants, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (84% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01656681, a NA study of Obesity, has completed, sponsored by MetaProteomics.
- COMPLETED
- Registry status
- NA
- Development phase
- 130 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this 2-stage intervention study is to investigate the effect of a novel nutraceutical (containing tetrahydro iso-alpha acids derived from hops) on weight loss and weight loss maintenance in obese participants.
Primary Outcome
The primary endpoint is the absolute pounds of weight change from baseline to the end of the 64 weeks.
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Placebo
- DIETARY_SUPPLEMENT THIAA
Study Locations (1)
Washington
- Functional Medicine Research Center - Gig Harbor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 130 participants |
| Start Date | 2011-05 |
| Est. Completion | 2012-12 |
| Phase | NA |
What the finished NCT01656681 record still lists
NCT01656681 is an interventional study that assigns participants to a tested intervention. The registered 130 participants enrollment target is mid-sized for trials with a published cap, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (84% lower).
The record links to 1 condition, with Obesity appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT01656681 reports a single indexed study location in Washington.
Frequently Asked Questions
What is clinical trial NCT01656681 about?
NCT01656681 is a clinical study titled "Effect of a Novel Nutraceutical on Weight Loss and Weight Maintenance in Obese Subjects". The purpose of this 2-stage intervention study is to investigate the effect of a novel nutraceutical (containing tetrahydro iso-alpha acids derived from hops) on weight loss and weight loss maintenance in obese participants.
What is the current status of trial NCT01656681?
This trial is currently completed. It is a NA study. The enrollment target is 130 participants. The study started on 2011-05. Estimated completion is 2012-12.
What conditions does trial NCT01656681 study?
This clinical trial studies the following conditions: Obesity.
What interventions are being tested in trial NCT01656681?
The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), THIAA (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT01656681?
This trial is sponsored by MetaProteomics, which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01656681 being conducted?
This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Obesity
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01656681's enrollment target sits among peer trials
130 418th of 1053 higher than 633 of 1,053 other Obesity trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Obesity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Metabolic Adaptations to Weight Loss With and Without Exercise
RECRUITING · NA
-
Testing an Integrated PTSD and Weight Management Intervention: A Hybrid Type 1 Trial
RECRUITING · NA
-
Tai Chi as a Novel Strategy to Increase Physical Activity Among Adults Pursuing Metabolic and Bariatric Surgery
RECRUITING · NA
-
Mechanistic and Clinical Outcomes of a Surgical Innovation Aimed at Minimizing GERD Associated With VSG (INNOVATE-VSG)
RECRUITING · NA
-
SMARTer Weight Loss Management
RECRUITING · NA
-
HealthyTogether: RCT of a Dyadic Weight Management Intervention
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01492036 · 130 participants
Long-Term Follow-Up of Recipient of Gene Transfer Research
- NCT01631617 · 130 participants · Phase 2
Effects of Treatments on Atopic Dermatitis
- NCT02368041 · 130 participants
Utility of Thenar Near Infrared Spectroscopy (NIRS) in Pediatric Patients With Heart Failure
- NCT02604277 · 130 participants · NA
Suicidal Behavior in Patients Diagnosed With Bipolar Disorder
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia